insights_auto
Why is AGIO up ၂.၅၈%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
၃၃.၄၂ US$
arrow_upward
+၂.၅၈%(+၀.၈၄) 1D
၃၃.၄၂ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: စက် ၂၈, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
၃၂.၅၃ US$
High
၃၄.၁၂ US$
Low
၃၂.၃၅ US$
Mkt. cap
၁၉၉.၅၂ ဋေ
Avg. vol.
၉.၃၅ သိန်း
Volume
၂၃.၀၀
52-wk high
၄၅.၉၉ US$
52-wk low
၂၂.၂၄ US$
EPS
-၇.၀၁ US$
Beta
၀.၆၀
Shares outstanding
၅.၉၇ ကုဋေ
No. of employees
၅၄၀
Open
၃၂.၅၃ US$
High
၃၄.၁၂ US$
Low
၃၂.၃၅ US$
Mkt. cap
၁၉၉.၅၂ ဋေ
Avg. vol.
၉.၃၅ သိန်း
Volume
၂၃.၀၀
52-wk high
၄၅.၉၉ US$
52-wk low
၂၂.၂၄ US$
EPS
-၇.၀၁ US$
Beta
၀.၆၀
Shares outstanding
၅.၉၇ ကုဋေ
No. of employees
၅၄၀
News stories
From web sources and news partners
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၂ လ
AGIO Q1 2026 Earnings: Narrower-than-Expected Loss on Cost Discipline - Non-GAAP Earnings
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc